IIM
EDIT icon

INTECH Investment Management’s Editas Medicine EDIT Stock Holding History

INTECH Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.1K Sell
25,663
-621
-2% -$1.81K ﹤0.01% 1977
2026
Q1 		$64.9K Sell
26,284
-13,458
-34% -$28.5K ﹤0.01% 1972
2025
Q4 		$81.5K Sell
39,742
-2,493
-6% -$7.2K ﹤0.01% 2192
2025
Q3 		$147K Sell
42,235
-4,954
-10% -$13.8K ﹤0.01% 2161
2025
Q2 		$104K Sell
47,189
-27,414
-37% -$44.9K ﹤0.01% 2283
2025
Q1 		$86.5K Buy
74,603
+33,661
+82% +$49.5K ﹤0.01% 2350
2024
Q4 		$52K Buy
40,942
+12,336
+43% +$31.4K ﹤0.01% 2323
2024
Q3 		$97.5K Buy
+28,606
New +$125K ﹤0.01% 1886

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

INTECH Investment Management's EDIT Position: Q2 2026 in Review

INTECH Investment Management reduced its Editas Medicine (EDIT) stake by 2.4% in Q2 2026, selling an estimated $1.81K and leaving 25,663 shares worth $83.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1977.

INTECH Investment Management first reported a position in EDIT in Q3 2024 and has held it in 8 quarters since. The position peaked at $147K in Q3 2025. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • INTECH Investment Management held 25,663 shares of Editas Medicine worth $83.1K as of Q2 2026.
  • INTECH Investment Management sold 621 Editas Medicine shares in Q2 2026, an estimated $1.81K.
  • Editas Medicine made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1977 holding.
  • INTECH Investment Management first reported a position in Editas Medicine in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Editas Medicine position peaked at $147K in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.